Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Other than from one of the analysts, no mention of QSM by managment, even in the response to that analyst.
Would love to hear that announcement at next CC ^_^
Personally, I would find it strange that a doctor who sees their patient only 3 to 4 times a year would write anything less than a 3-month renewal script. Otherwise, the patient could effectively be left with no medication, no?
And I think your point, Joeblack, is another good reason to think the same.
Thanks for sharing, whogo.
Interesting. Two of the three comments so far discuss cost as a factor that would likely prevent them from choosing Otrexup over self-injecting.
A big day that has indeed been long awaited. GLA.
Happy new year, Chef and all!
Happy holidays, all!
Happy holidays, all!
I think we also need to remember that ATRS will likely offer promotions/discounts on Otrexup on launch. This is standard practice, no? Not sure what kind of discounts we'd be talking though.
Thanks, Jab. Curious -- what makes you think the epi-pen improvement is in cahoots with ATRS? My first, albeit uneducated-based instinct, was fearing that Teva was doing some sort of newer/better injector on its own. But i have no evidence of this. Just curious to know what you think / why you believe the improvement necessarily involves ATRS.
Regards,
Silvrmoon
Nice pickup, Jab. Very interesting...
Thanks Bsav. I have also picked up a few shares due to your recommendation. Will likely add a bit more in the near future. Maybe one day we can all break bread together.
Go Scrc (and Atrs).
If I remember correctly, about 1.5 million warrants left(?)
Thanks for sharing.
An interesting read from a former penny stock promoter:
http://www.reddit.com/r/investing/comments/158vi7/i_used_to_be_a_penny_stock_promoter_in_the_late/?sort=confidence
Personally, I don't think, even if we had the money, that kind of advertising would be worth it. I think the currently targeted campaign is by far optimal -- i.e. targeting the prescribers, rather than the patients. There are only ~3,000 RA doctors, who I believe are, by far, the main prescribers of methotrexate.
I'm still here. Nice to hear from you Bsav.
Great article. Thanks for sharing all.
"Methotrexate OK as Therapy for Retina Disorder"
Great article find explorermadc!
I hope they rework the ATRS page while they are at it... needs a makeover, I think :/
Great letter! Thank you for sharing!
Vibex instructions, diagram & prescribing information
Released on the main Antares webpage. Page 25-27 of the PDF have the instructions for the injector with diagrams. Link to pdf.
Personally, don't care. This is similar action to what we saw on Anturol/Gelnique approval. Fundamentally, the significant component of our pipeline model has been approved today. I am happy with that. Let the traders churn for a bit.
Curious to see the potentially unexpected effect of all the labels it was approved for. We weren't sure if it was going to get approved for all those.
Congrats ladies & gents.
I should also add that he expressed a positive sentiment with respect to the quality of application they put forward to the FDA. And with respect to the date, he was ambivalent -- "it doesn't matter one way whether it comes Monday or Tuesday," which many others on here have iterated before, which I think is a positive view.
Silvrmoon
Just got off the phone with Jack. Good guy. Points from conversation:
- No idea how the holiday affects the PDUFA date ("the FDA doesn't tell anyone anything")
- Presumes, like us, backed by Ryman's previous post, that the FDA is still working during the shutdown, to some degree or capacity (he referenced the recent Pfizer approval)
- "While we are waiting like everyone else, we are however more focused on preparing for the launch." Liked hearing that.
My take from all this then, similar to usma's below, is we hear the PDUFA decision at close today, or open/close on the 15th.
Feel free to share the above with the YMB folk (won't have time today to do it myself).
Regards,
Silvrmoon
I tried to call Jack earlier today to see if he had heard whether the shutdown and/or holiday would affect the PDUFA decision date, but he was away.
Thank you and Ryman for answering!
Was this a predetermined "auto sell", Ryman?
Maybe we'll get a refund if they're late :/
haha Jab -- you kill me. Thanks for going straight the horse's mouth on this one. I like Jack's ability/want to defuse rumors.
Interesting, thanks Ryman
Diddo. Thanks for the analysis Bsav!
Honestly, it's amazing how LD finds this stuff!
Thanks for sharing your thoughts TD. I would never have picked up on the "molecule" bit.
Feeling the love Jab. And I have to say, of all the AIS/ATRS CCs I have listened to, this last one I believe set a record for the number of institutions that asked questions. At least five I believe. People are curious!
Thanks for sharing Ryman.
haha... i was thinking the same earlier tigr.